Markova, M., Hristov, G. Reporting of R&D costs under IAS 38 - the case of biopharmaceutical companies,
, 2022, 57-65.
Markova, M., Hristov, G. .
Reporting of R&D costs under IAS 38 - the case of biopharmaceutical companies.
София: , 2022, 57-65.
Markova, M., Hristov, G. (2022)
Reporting of R&D costs under IAS 38 - the case of biopharmaceutical companies,
София: , 57-65
Markova, M., & Hristov, G.
(2022).
Reporting of R&D costs under IAS 38 - the case of biopharmaceutical companies. Научни трудове на УНСС, LXII (4), 57-65.
